4//SEC Filing
WESSON BRUCE F 4
Accession 0001104659-24-000283
CIK 0000786947other
Filed
Jan 1, 7:00 PM ET
Accepted
Jan 2, 3:20 PM ET
Size
10.1 KB
Accession
0001104659-24-000283
Insider Transaction Report
Form 4
WESSON BRUCE F
Director
Transactions
- Disposition to Issuer
Restricted Stock Units (2021 Plan)
2024-01-02−12,500→ 0 total→ Common Stock (0 underlying) - Exercise/Conversion
Common Stock
2024-01-02+37,500→ 829,548 total - Exercise/Conversion
Restricted Stock Units (2021 Plan)
2024-01-02−37,500→ 12,500 total→ Common Stock (37,500 underlying)
Footnotes (7)
- [F1]Represents exchange of restricted stock units.
- [F2]Par value of $.01 per share must be paid by Reporting Person upon exchange of Restricted Stock Units for stock
- [F3]Does not include Restricted Stock Units.
- [F4]1 - for - 1
- [F5]50,000 Restricted Stock Units were granted on January 3, 2023. 25% of Restricted Stock Units vested on the last day of each of March, June, and September 2023. Restricted Stock Units are being exchanged on a one for one basis for common stock, in each case upon payment of par value.
- [F6]N/A
- [F7]25% of the 50,000 Restricted Stock Units granted on January 3, 2023 did not vest and were forfeited due to the departure of the Director in September 2023.
Documents
Issuer
ACURA PHARMACEUTICALS, INC
CIK 0000786947
Entity typeother
Related Parties
1- filerCIK 0001058190
Filing Metadata
- Form type
- 4
- Filed
- Jan 1, 7:00 PM ET
- Accepted
- Jan 2, 3:20 PM ET
- Size
- 10.1 KB